Oorsprong van het eerstegraads netwerk van Claudio Dansky Ullmann
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claudio Dansky Ullmann via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Medical Specialties | Director of Finance/CFO | |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Providence College | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Director/Board Member | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Director/Board Member | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Chief Executive Officer | |
Primex Pharmaceuticals AG
 Primex Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals AG operates as a pharmaceutical company which develops, manufactures, and markets healthcare products and medicines to consumers and healthcare professionals. The company was founded by Kari Sarvanto in 2008 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Culture Biosciences, Inc.
 Culture Biosciences, Inc. Packaged SoftwareTechnology Services Culture Biosciences, Inc. operates as biotech company advancing bio-manufacturing as a service. The company was founded by William Patrick and Matthew Ball in 2016 and is headquartered in South San Francisco, CA. | Packaged Software | Chief Operating Officer | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Executive Officer | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Université Jean Moulin Lyon 3 | College/University | Undergraduate Degree | |
| University of Lyon | College/University | Doctorate Degree | |
| Universite Lumiere Lyon 2 | College/University | Graduate Degree | |
Groupe GlaxoSmithKline SAS
 Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Part of GSK Plc, Groupe GlaxoSmithKline SAS is an investment holding French company. The company is based in Rueil-Malmaison, France. | Financial Conglomerates | Chief Executive Officer | |
Takeda Pharmaceuticals (Asia Pacific) Pte Ltd.
 Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. Drugstore ChainsRetail Trade Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. sales pharmaceutical products. The company was founded on April 5, 2012 and is headquartered in Singapore. | Drugstore Chains | Chief Executive Officer | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member | |
Labatec Pharma SA
 Labatec Pharma SA Pharmaceuticals: MajorHealth Technology Labatec Pharma SA engages in the provision of pharmaceutical business. Its products include injectable and orals for hospital use, specialty retail prescription, and over-the-counter products and supplements. The company was founded in 1957 and is headquartered in. | Pharmaceuticals: Major | Director/Board Member | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
| TOA CORPORATION | Engineering & Construction | Director/Board Member | |
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Founder | |
| CELLSEED INC. | Pharmaceuticals: Other | Director/Board Member | |
HuBit Genomix KK
 HuBit Genomix KK Miscellaneous Commercial ServicesCommercial Services HuBit Genomix KK is a Japanese pharmaceutical development company that conducts clinical trials and research on pharmaceuticals to develop diagnostic drugs. The company is based in Tokyo, Japan. The company analyzes and utilize valuable information to create "diagnosis methods" and "pharmaceuticals" that satisfy medical amenities. HuBit Genomix KK was acquired by Celera Group on March 20, 2001. | Miscellaneous Commercial Services | President | |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan. | Chemicals: Agricultural | President | |
Life Science Management, Inc.
 Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Management, Inc. provides consulting services for businesses in the life science and healthcare industries. The Japanese company's focus is on helping these businesses to succeed and grow. | Miscellaneous Commercial Services | President | |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Primex Pharmaceuticals Oy
 Primex Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Primex Pharmaceuticals Oy manufactures and markets healthcare products. The fims's products include Dobuject and Recofol N. It also produces several other products for anesthesia and intensive care. The company was founded by Mikko Laiho, Pekka Leinonen, Janne Kovalainen, Kari Sarvanto and Jany Mengelkamp in 2008 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi. | Miscellaneous Commercial Services | Director/Board Member | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Tokyo | College/University | Doctorate Degree | |
The Children's Mercy Hospital
 The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services The Children's Mercy Hospital provides pediatric health care services. It offers abdominal pain program, adolescent medicine, anesthesiology, bioethics, bone marrow transplantation, burn and trauma care, cardiology, child abuse and neglect, cleft palate and craniofacial, dentistry, dermatology, down syndrome clinic, eating disorders center, endocrinology and diabetes, epilepsy center, fetal health center, gastroenterology, genetics, gynecology, hand clinic and surgery, hematology, heart center, imaging, kidney and liver transplant, medical imaging, neonatology, neurology, nutrition services, ophthalmology, pain management, pathology and laboratory medicine, pharmacology, radiology, respiratory care, sexual differentiation treatment, sleep disorders program, surgery, telemedicine, urgent care, urologic surgery, and weight management services. The company was founded in June 1897 and is headquartered in Kansas City, MO. | Hospital/Nursing Management | Corporate Officer/Principal | |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 22 |
| Japan | 13 |
| Frankrijk | 5 |
| Zwitserland | 3 |
| België | 3 |
Sectoraal
| Health Technology | 27 |
| Commercial Services | 8 |
| Consumer Services | 7 |
| Finance | 6 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 106 |
| Corporate Officer/Principal | 62 |
| Independent Dir/Board Member | 31 |
| Chief Executive Officer | 23 |
| President | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Frank Morich | 21 |
| Deborah Dunsire | 20 |
| François-Xavier Roger | 17 |
| Michael Martin | 17 |
| Hiromichi Kimura | 16 |
| Ralf Clemens | 14 |
| Karen Ferrante | 14 |
| Anna Protopapas | 12 |
| Masahiro Sakane | 10 |
| Christophe Weber | 10 |
| Shiro Kuniya | 9 |
| Jostein Davidsen | 8 |
| Iwaaki Taniguchi | 7 |
| Yan Zhu | 7 |
| Elena Cant | 6 |
- Beurs
- Insiders
- Claudio Dansky Ullmann
- Bedrijfsconnecties
